Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital 2024-08-29 10:00
Necessary Care or Abuse? Unpacking the Reason Behind Overprescription 2024-08-29 08:30
Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024 2024-08-29 08:00
Innovent Announces 2024 Interim Results and Business Updates 2024-08-28 18:42
Everest Medicines Announces Interim Results for First Half of 2024 2024-08-28 08:00
Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent 2024-08-28 07:53
Unique International Collaboration Brings Breakthrough Oral Cholera Vaccine to Market 2024-08-28 00:00
Boan Biotech Announces 2024 Half Year Results: Revenue Grows by 39%, Net Profit Increases by RMB 180 Million 2024-08-27 22:55
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study 2024-08-27 20:05
JW Therapeutics Announces NMPA Approval of the Supplemental Biological License Application for Carteyva® in Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma 2024-08-27 17:00
ArkBio Presented at the 8th Annual IPF Summit and Announced Completion of Patient Enrollment for Phase 2 Clinical Trial of AK3280, a Next-Generation Drug for IPF Treatment 2024-08-27 09:00
Fujitsu tackles 'drug loss' in Japan through ecosystem to accelerate digitalization of clinical trials 2024-08-27 08:07
Telix Announces Reorganisation to Deliver on Strategic Priorities 2024-08-27 07:15
Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration 2024-08-26 21:00
CStone Reports 2024 Interim Results and Recent Corporate Updates 2024-08-23 22:20
Antengene Announces 2024 Interim Financial Results, Highlights Progress in R&D and Commercialization 2024-08-23 12:32
Ascentage Pharma Announces 2024 Interim Results 2024-08-22 23:36
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities 2024-08-22 17:04
Inaugural Process Innovation Asia Pacific to Drive Industry Transformation for South-East Asia's Chemicals and Pharmaceuticals 2024-08-22 15:30
China's First Approved KRAS G12C Inhibitor: Innovent Announces the Approval of Dupert® (Fulzerasib) by the National Medical Products Administration of China 2024-08-22 08:00
1 2 3 4 5 241